Gabapentin and Acarodermatitis - a phase IV clinical study of FDA data

Summary:

Acarodermatitis is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are female, 60+ old, also take Lipitor, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Acarodermatitis when taking Gabapentin. It is created by eHealthMe based on reports of 313,421 people who have side effects when taking Gabapentin from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.

What is Acarodermatitis?

Acarodermatitis (skin inflammation caused by mites (acarids)) is found to be associated with 209 drugs and 311 conditions by eHealthMe. Check the latest studies of Acarodermatitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

313,421 people reported to have side effects when taking Gabapentin.
Among them, 28 people (0.01%) have Acarodermatitis.

Among these 28 people:

What is the gender of people who have Acarodermatitis when taking Gabapentin? *

female: 65.38 %
male: 34.62 %

What is the age of people who have Acarodermatitis when taking Gabapentin? *

What are other drugs people take besides Gabapentin? *

What are other side effects people have besides Acarodermatitis? *

Rashes (redness): 14 people, 50.00%
Weakness: 11 people, 39.29%
Oedema Peripheral (superficial swelling): 8 people, 28.57%
Fever: 7 people, 25.00%
Nausea (feeling of having an urge to vomit): 7 people, 25.00%
Fatigue (feeling of tiredness): 7 people, 25.00%
Rash Pruritic (redness with itching): 7 people, 25.00%
Wheezing (a high-pitched whistling sound made while you breath): 7 people, 25.00%
Pneumonia: 6 people, 21.43%
Weight Increased: 6 people, 21.43%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 14.29%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.71%
Depression: 3 people, 10.71%
Thrombocytopenia (decrease of platelets in blood): 3 people, 10.71%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 10.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.71%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 7.14%
High Blood Cholesterol: 2 people, 7.14%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 7.14%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and have Acarodermatitis?

- Check whether Acarodermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gabapentin:

Gabapentin (322,987 reports)

Acarodermatitis treatments and more:

Acarodermatitis (2,497 reports)

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acarodermatitis:

Acarodermatitis (209 drugs)

Browse all the conditions that are associated with Acarodermatitis:

Acarodermatitis (311 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.